Bristol Myers Squibb reports $13.07 billion revenue for quarter ended September 30, 2026, up 6.9%

ยท BMY

Bristol Myers Squibb reported revenue of $13.07 billion for the quarter ended September 30, 2026, an increase of 6.9% from the same quarter a year earlier ($12.22 billion).

For the same period it posted net income of $2.16 billion, down 1.8%, or $1.05 per diluted share (1.08 a year earlier).

That is a net margin of 16.5%.

On Sanad's AAOIFI Standard 21 screen, Bristol Myers Squibb is currently not compliant: interest-bearing debt is 34.8% of market capitalisation (limit 30%), and impure income is 1.2% of revenue (limit 5%).

Source: 10-Q filed with the U.S. Securities and Exchange Commission on October 29, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.

More Bristol Myers Squibb news